Proteros biostructures GmbH
Proteros biostructures GmbH Announces Election of Prof. Eric-Paul Pâques, CEO of Grünenthal, as New Supervisory Board Member

Proteros Announces Election of Prof. Eric-Paul Pâques, CEO of Grünenthal, as New Supervisory Board Member

Munich, Germany – 20 February 2014 – Proteros biostructures announced today that its shareholders confirmed the appointment of Prof. Eric-Paul Pâques as a new member of the Supervisory Board. Prof. Pâques is presently CEO and Chairman of the Corporate Executive Board of Grünenthal, an international research-based pharmaceutical company headquartered in Aachen, Germany. Prior to his more than 20 years at Grünenthal, he worked as the Head of Research at Behringwerke AG, in Germany. Prof. Pâques received a doctorate in Chemistry from the Université Catholique de Louvain.

‘We are delighted to have Eric-Paul joining our board’ commented Dave Lemus, Chairman of the Supervisory Board of Proteros. ‘His extensive experience in the pharmaceutical industry will prove invaluable to Proteros as the company accelerates its transition to the next phase of its development.’

About Proteros biostructures GmbH
Proteros biostructures, located in Martinsried/Munich, is a privately-held company, focussing on protein-structure accelerated lead discovery. Proteros has established a unique and powerful platform for the integration of protein crystallography, biophysics – particularly kinetic and thermodynamic profiling-, tailor-made protein production for biophysical applications and Medicinal Chemistry. Proteros collaborates with more than 80 pharmaceutical and biotechnology clients in North America, Europe and Asia. For more information, visit: www.proteros.com

Contacts:
Dr. Torsten Neuefeind, CEO
Proteros biostructures GmbH
Email: neuefeind@proteros.de

For Press enquiries:
MC Services AG, Katja Arnold
Email: katja.arnold@mc-services.eu
Phone: +49 89 210 228-0